Inventor · disambiguated record
Junghoon Yang
Also filed as: YANG JUNGHOON
7 granted patents·4 pending applications·21 citations·filing 2021–2023
80Inventor score
Files withORNA THERAPEUTICS INC11
Top patents by PatentIndex Score
11 records- 0197US11679120B2Circular RNA compositions and methodsORNA THERAPEUTICS INC·Filed 2021·Granted Jun 20, 2023·11 cites·19 claims
- 0296US11766449B2Circular RNA compositions and methodsORNA THERAPEUTICS INC·Filed 2021·Granted Sep 26, 2023·8 cites·23 claims
- 0393US11771715B2Circular RNA compositions and methodsORNA THERAPEUTICS INC·Filed 2021·Granted Oct 3, 2023·2 cites·25 claims
- 0486US12415776B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Sep 16, 2025·0 cites·28 claims
- 0586US12384741B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Aug 12, 2025·0 cites·28 claims
- 0686US12180138B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·0 cites·28 claims
- 0786US12077485B2Lipid nanoparticle compositions for delivering circular polynucleotidesORNA THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·28 claims
- 0880US2024131049A1Circular rna compositions and methodsORNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0964US2025099621A1Systemic administration of circular rna polynucleotides encoding muscle proteins or protein complexesORNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1062US2025268828A1Lipid Nanoparticle Compositions for Delivering Circular PolynucleotidesORNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1154US2023226096A1Circular rna compositions and methodsORNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Junghoon Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →